Blood Thinner Improves Survival for Diabetics Receiving Stents
Other experts agree that the drug could help diabetics who undergo coronary artery procedures.
"It does represent a potential advance for diabetics who are dealing with coronary artery disease," says Leroy Rabbani, MD, director of coronary care at Columbia Presbyterian Medical Center. However, patients who have narrowing of all three coronary arteries would still be better off with a heart bypass, he says. Rabbani was not involved in the study, which was funded by Centrocor Inc. and Eli Lilly and Company, the producer and distributor, respectively, of Reopro.
Spencer King, MD, director of interventional cardiology at Emory University of Medicine, calls the findings a "technical innovation." King, who was not involved in the study, says, "I think it's a fascinating finding, but it needs independent confirmation."